Blockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel Disease

• Autores principales: Guangxi Zhou (Autor), Lin Yu (Autor), Wenjing Yang (Autor), Wei Wu (Autor), Leilei Fang (Autor), Zhanju Liu (Autor)
• Formato: Libro
• Publicado: Hindawi Limited, 2016-01-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background. Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronically remittent and progressive inflammatory disorders. Phospholipase D2 (PLD2) is reported to be involved in the pathogenesis of several inflammatory diseases. However, the exac...